You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer

    SBC: ACTORIUS PHARMACEUTICALS, LLC            Topic: 100

    DESCRIPTION provided by applicant Breast cancer is the most common type of cancer in women between the ages of and and responsible for deaths annually If treated early five year survival rates for patients in the U S are between and but drop to once metastatic breast cancer has developed Thus there is a great need to develop more effective treatment strategies fo ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis

    SBC: Sanguine Diagnostics And Therapeutics, Inc.            Topic: 103

    ABSTRACT Pancreatic cancer PC is an extremely aggressive malignancy with one of the worst prognoses of all cancers with a median survival of less than one year and an overall year survival of andlt With marked resistance to chemo and radiotherapies surgery is the only curative option In patients with localized disease and no lymph node or extra pancreatic metastases complete surgical ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. STTR Phase I: The use of wrist-worn devices and sensory stimulation for evaluating sleep

    SBC: Mobile Sleep Technologies L.L.C            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve people's lives by creating the first wrist-based device that can reliably assess sleep quality. A large pool of undiagnosed patients and the growing population of the elderly point to a massive end-user market for sleep disorder diagnostics devices. The market is steadily increas ...

    STTR Phase I 2016 National Science Foundation
  4. STTR Phase I: Piezoelectric Fatigue Fuse Based Wireless Sensor Network

    SBC: Metal Fatigue Solutions Inc.            Topic: EW

    The broader impact/commercial potential of this project is to establish a precedence for remote, real time assessment of the safety and serviceability of infrastructural assets through the development of a self-powered structural health monitoring system. This piezoelectric fatigue fuse (PFF) will enable the establishment of quantifiable metrics to discern the current state of life as well as proj ...

    STTR Phase I 2016 National Science Foundation
  5. Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists

    SBC: Bohemica Pharmaceuticals, LLC            Topic: 100

    DESCRIPTION provided by applicant Therapeutics based on nucleic acids NA promise to revolutionize treatment of multiple diseases but their widespread use is currently limited by the lack of efficient delivery methods We have recently developed a new NA delivery platform based on polymeric CXCR inhibitors PCX suitable as dual function systems for simultaneous NA delivery and inhibition of ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Mutation Enriched Targeted Re Sequencing

    SBC: TRANSGENOMIC, INC.            Topic: 103

    DESCRIPTION provided by applicant Low level tumor associated somatic DNA mutations can have profound implications for development of metastasis prognosis choice of treatment follow up or early cancer detection Unless they are effectively detected these low level mutations can misinform patient management decisions or become missed opportunities for personalized medicine Widely used tech ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  7. STTR Phase I: Optimized Nano-Porous Surfaces for Boiling Heat Transfer

    SBC: ADVANCED MATERIALS & DEVICES            Topic: AM

    The Small Business Technology Transfer Research (STTR) Phase I project aims at developing a heat exchanger technology utilizing a homogeneous nano-porous surface (NPS) that will significantly increase the efficiency of the boiling process. The NPS technology offers considerable enhancement in boiling heat transfer capabilities for small- to large-size heat generating facilities, power plants, and ...

    STTR Phase I 2008 National Science Foundation
  8. STTR Phase II: Low-Cost Nanoparticles for Enhanced Heat Transfer

    SBC: ADVANCED MATERIALS & DEVICES            Topic: CT

    This STTR Phase II project is to develop and commercialize copper nanofluids for heat transfer enhancement applications. The low cost nanoparticle production methods developed will produce quality nanoparticles for this application. Success of this STTR project will benefit a wide range of applications for heat transfer enhancement including: electronics, HVAC, transportation, textile and paper m ...

    STTR Phase II 2008 National Science Foundation
  9. STTR Phase I:Printable flexible TiO2 photoanodes for solar energy conversion and hydrogen generation

    SBC: ALTAIRNANO, INC.            Topic: AM

    The Small Business Technology Transfer Research (STTR) Phase I project focuses on the production of a flexible, low cost, solar cell which can be used for the conversion of solar radiation to electricity or hydrogen. The proposed work will involve working on increasing the efficiency of the dye sensitized solar cell by increasing the connectivity of the anatase network in a low temperature scalab ...

    STTR Phase I 2008 National Science Foundation
  10. Transmucosal Intra-Oral Drug Delivery System for THC

    SBC: ElSohly Laboratories, Incorporated            Topic: N/A

    DESCRIPTION (provided by applicant): Delta-9-Tetrahydrocannabinol (THC), the active ingredient in the cannabis plant, has a wide range of pharmacological properties of therapeutic value. The drug has been approved by the Food and Drug Administration (FDA) (Marinol(r) soft gelatin capsules) for the treatment of nausea and vomiting associated with chemotherapy and for appetite stimulation in AIDS p ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government